Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R, Herrstedt J, Rapoport B, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans JK, Horgan KJ. de Wit R, et al. Eur J Cancer. 2004 Feb;40(3):403-10. Eur J Cancer. 2004. PMID: 14746859 Clinical Trial.
Optimal control of acute cisplatin-induced emesis.
Verweij J, de Wit R, de Mulder PH. Verweij J, et al. Among authors: de wit r, de mulder ph. Oncology. 1996 Jun;53 Suppl 1:56-64. doi: 10.1159/000227642. Oncology. 1996. PMID: 8692553 Review.
A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients.
de Wit R, Kruit WH, Lamers CH, van 't Veer MB, Luyten AA, van Beurden V, Harteveld M, Planting AS, Schmitz PI, Stoter G, Bolhuis RL, Verweij J. de Wit R, et al. Br J Cancer. 1998 Jun;77(12):2363-6. doi: 10.1038/bjc.1998.392. Br J Cancer. 1998. PMID: 9649159 Free PMC article. Clinical Trial.
460 results